Genome-based prediction offers a way to shortlist bacteriophages for laboratory testing. The crucial distinction is between a useful match and a proven treatment.
Study published 29 Sep 2026.
A new laboratory study examines how a modified RNA base can affect protein translation—and how sequence design can reduce a particular reading error.
An engineered sugar-bearing gel inhibits bacterial growth and biofilms in laboratory tests. Its promise depends on more than looking or behaving like natural mucus.
A new intestinal atlas connects genetic signals to candidate regulatory regions. It helps refine biological questions about Crohn’s disease without turning an association into a treatment promise.
A new human brain atlas offers a closer view of ageing. Its real value lies in the questions it makes possible, rather than a personal biological-age score.
A fruit-fly experiment raises a precise question about ageing: which part of a nutrient response matters? The answer needs to be separated from the much broader promise of living longer.
A molecular map asks what familiar anatomical boundaries leave out. Here is how to read its colourful regions without mistaking a new classification for a clinical breakthrough.
A September review asks who produces the evidence behind digital health tools. For readers, the practical task is to inspect both the result and the route that produced it.
A new study follows research published after the original trial report. It raises a useful distinction: more papers, new investigators and new participants are three different things.
Find the missing denominator, connect results and ask better questions. Our evidence toolkit gives you a place to start.
Open the evidence toolkitOne question. A connected reading path. Institutional announcements and earlier coverage, preserved at their original addresses. The collection begins in 2010.
Browse the press release archive